Device Trial Radar · NCT03119233
The DETOUR 2 Clinical Trial
Last checked: Nov 20, 2026Latest source record: Apr 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
202
Actual
Start
Dec 13, 2017
Primary completion
Dec 22, 2021
Study completion Nov 13, 2023
Sponsor
- Lead sponsor
- EndologixNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 18, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, single-arm, multi-center, international clinical investigation to evaluate the safety and effectiveness of the PQ Bypass System to access, deliver guidewires, and implant stent grafts for a percutaneous femoropopliteal (fem-pop) bypass.
Conditions
- Peripheral Arterial Disease
Interventions
DETOUR SystemDevice
The DETOUR System is intended to improve blood flow in patients with peripheral arterial disease in symptomatic femoropopliteal lesions due to chronic total occlusions ≥ 20 cm (TASC D) that can include de novo, restenotic, or in-stent restenotic lesions; or total lesion lengths ≥24 cm that can include chronic total occlusions or a ≥70% lesion that includes de novo, restenotic or in-stent restenosis (complex TASC C).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary PatencyTime frame: 12 months
- Major Adverse Events at 30 DaysTime frame: 30 days
Locations
34 sites in 3 countries. Site status is shown where the registry gives one.
HonorHealth
Scottsdale, Arizona
St. Bernard's Medical Center
Jonesboro, Arkansas
Arkansas Heart Hospital
Little Rock, Arkansas
31 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.